Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MXCN

Maxcyte (MXCN)

Maxcyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:MXCN
DateTimeSourceHeadlineSymbolCompany
13/03/202407:05UK RegulatoryMaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceLSE:MXCNMaxcyte Inc
05/03/202408:05UK RegulatoryMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary ResultsLSE:MXCNMaxcyte Inc
10/02/202400:05UK RegulatoryMaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor ConferencesLSE:MXCNMaxcyte Inc
31/01/202400:05UK RegulatoryMaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for CancersLSE:MXCNMaxcyte Inc
09/08/202116:00PR Newswire (US)MaxCyte Signs Clinical and Commercial License with Sana BiotechnologyLSE:MXCNMaxcyte Inc
31/07/202101:07PR Newswire (US)DLA Piper advises underwriters of MaxCyte's upsized US IPOLSE:MXCNMaxcyte Inc
30/07/202113:05PR Newswire (US)MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select MarketLSE:MXCNMaxcyte Inc
30/07/202112:42PR Newswire (US)MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select MarketLSE:MXCNMaxcyte Inc
26/07/202121:49PR Newswire (US)MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global MarketLSE:MXCNMaxcyte Inc
12/07/202116:00PR Newswire (US)MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual ListingLSE:MXCNMaxcyte Inc
12/07/202116:00PR Newswire (US)Financial information in the Form S-1 registration statement and Change to Board of DirectorsLSE:MXCNMaxcyte Inc
14/05/202116:00PR Newswire (US)Proposed Dual-Listing on NasdaqLSE:MXCNMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCN